Source:http://linkedlifedata.com/resource/pubmed/id/10068585
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1999-4-21
|
pubmed:abstractText |
Despite the significant impact on human health of Streptococcus pyogenes, an efficacious vaccine has not yet been developed. Here, the potential as a vaccine candidate of a major streptococcal adhesin, the fibronectin-binding protein SfbI, was evaluated. Intranasal immunization of mice with either SfbI alone or coupled to cholera toxin B subunit (CTB) triggered efficient SfbI-specific humoral (mainly IgG) and lung mucosal (14% of total IgA) responses. CTB-immunized control mice were not protected against challenge with S. pyogenes (90%-100% lethality), whereas SfbI-vaccinated animals showed 80% and 90% protection against homologous and heterologous challenge, respectively. Multiple areas of consolidation with diffused cellular infiltrates (macrophages and neutrophils) were observed in lungs from control mice; the histologic structure was preserved in SfbI-vaccinated animals, which occasionally presented focal infiltrates confined to the perivascular, peribronchial, and subpleural areas. These results suggest that SfbI is a promising candidate for inclusion in acellular vaccines against S. pyogenes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adhesins, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Vaccines,
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/fibronectin-binding proteins...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
179
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
901-6
|
pubmed:dateRevised |
2010-10-19
|
pubmed:meshHeading |
pubmed-meshheading:10068585-Adhesins, Bacterial,
pubmed-meshheading:10068585-Administration, Intranasal,
pubmed-meshheading:10068585-Animals,
pubmed-meshheading:10068585-Antibodies, Bacterial,
pubmed-meshheading:10068585-Bacterial Proteins,
pubmed-meshheading:10068585-Bacterial Vaccines,
pubmed-meshheading:10068585-Carrier Proteins,
pubmed-meshheading:10068585-Female,
pubmed-meshheading:10068585-Immunity, Mucosal,
pubmed-meshheading:10068585-Lung,
pubmed-meshheading:10068585-Mice,
pubmed-meshheading:10068585-Mice, Inbred BALB C,
pubmed-meshheading:10068585-Streptococcus pyogenes,
pubmed-meshheading:10068585-Vaccination
|
pubmed:year |
1999
|
pubmed:articleTitle |
Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI.
|
pubmed:affiliation |
Department of Microbial Pathogenicity and Vaccine Research, Division of Microbiology, GBF-National Research Centre for Biotechnology, 38124-Braunschweig, Germany. cag@gbf.de
|
pubmed:publicationType |
Journal Article
|